BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 22899753)

  • 1. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
    Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
    Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
    Funatsu H; Yamashita H; Noma H; Mimura T; Sakata K; Hori S
    Br J Ophthalmol; 2004 Aug; 88(8):1064-8. PubMed ID: 15258026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
    Funatsu H; Yamashita H; Mimura T; Noma H; Nakamura S; Hori S
    Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy.
    Sun C; Zhang H; Jiang J; Li Y; Nie C; Gu J; Luo L; Wang Z
    Int Ophthalmol; 2020 Feb; 40(2):467-475. PubMed ID: 31802372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy.
    Suzuki Y; Suzuki K; Kudo T; Metoki T; Nakazawa M
    Ophthalmologica; 2016; 236(3):133-138. PubMed ID: 27794575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.
    Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS
    Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy.
    Park UC; Park KH; Kim DM; Yu HG
    J Glaucoma; 2011 Sep; 20(7):433-8. PubMed ID: 20852440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
    Ma Y; Zhang Y; Zhao T; Jiang YR
    Am J Ophthalmol; 2012 Feb; 153(2):307-313.e2. PubMed ID: 21982107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
    Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.